Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025
Nautilus Biotechnology (NASDAQ: NAUT), a pioneer in single-molecule protein analysis platforms, has scheduled its Q2 2025 financial results announcement for July 31, 2025, before market open.
The company will host a conference call and webcast at 5:30 AM PT / 8:30 AM ET to discuss quarterly results, business developments, and future outlook. Investors can access the live webcast through the company's website at www.nautilus.bio.
Nautilus Biotechnology (NASDAQ: NAUT), pioniere nelle piattaforme di analisi proteica a singola molecola, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 31 luglio 2025, prima dell'apertura del mercato.
L'azienda terrà una conference call e una diretta webcast alle 5:30 AM PT / 8:30 AM ET per discutere i risultati trimestrali, gli sviluppi aziendali e le prospettive future. Gli investitori potranno seguire la diretta webcast sul sito web della società all'indirizzo www.nautilus.bio.
Nautilus Biotechnology (NASDAQ: NAUT), pionera en plataformas de análisis de proteínas a nivel de molécula única, ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el 31 de julio de 2025, antes de la apertura del mercado.
La compañía realizará una llamada conferencia y una transmisión en vivo a las 5:30 AM PT / 8:30 AM ET para discutir los resultados trimestrales, desarrollos comerciales y perspectivas futuras. Los inversores pueden acceder a la transmisión en vivo a través del sitio web de la empresa en www.nautilus.bio.
Nautilus Biotechnology (NASDAQ: NAUT)는 단일 분자 단백질 분석 플랫폼의 선구자로서, 2025년 7월 31일 2분기 2025년 재무 실적 발표를 시장 개장 전에 예정했습니다.
회사는 분기 실적, 사업 개발 및 향후 전망에 대해 논의하기 위해 오전 5:30 PT / 오전 8:30 ET에 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다. 투자자들은 회사 웹사이트 www.nautilus.bio를 통해 생중계 웹캐스트에 접속할 수 있습니다.
Nautilus Biotechnology (NASDAQ : NAUT), pionnier des plateformes d'analyse de protéines au niveau moléculaire unique, a programmé l'annonce des résultats financiers du deuxième trimestre 2025 pour le 31 juillet 2025, avant l'ouverture des marchés.
L'entreprise organisera une conférence téléphonique et une diffusion en direct à 5h30 PT / 8h30 ET pour discuter des résultats trimestriels, des développements commerciaux et des perspectives futures. Les investisseurs pourront accéder à la diffusion en direct via le site web de la société à l'adresse www.nautilus.bio.
Nautilus Biotechnology (NASDAQ: NAUT), ein Vorreiter bei Einzelmolekül-Proteinanalysplattformen, hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 am 31. Juli 2025 vor Börsenöffnung angekündigt.
Das Unternehmen wird um 5:30 Uhr PT / 8:30 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um die Quartalsergebnisse, Geschäftsentwicklungen und zukünftigen Ausblicke zu besprechen. Investoren können den Live-Webcast über die Website des Unternehmens unter www.nautilus.bio verfolgen.
- None.
- None.
SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the second quarter 2025 before market open on Thursday, July 31, 2025.
The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
FAQ
When will Nautilus Biotechnology (NAUT) release Q2 2025 earnings?
What time is the Nautilus Biotechnology (NAUT) Q2 2025 earnings call?
How can I listen to Nautilus Biotechnology's Q2 2025 earnings call?
What does Nautilus Biotechnology (NAUT) do?
